Toxoplasma gondii and the host cells

• Autorzy: Dlugonska H.
• Języki publikacji: EN

Abstrakty

EN

The protozoan Toxoplasma gondii, described by Nicolle and Manceaux in 1908, is a ubiquitous and cosmopolitan parasite that infects a wide range of mammal and bird species with high prevalence. The biological success of T. gondii is associated with the formation of a specific relationship between the parasite and host cells leading to the establishment of a latent, chronic infection. During primary infection, acquired mostly by the oral route, the quickly multiplying tachyzoites disseminate through the body crossing several structural-functional barriers as bloodbrain or blood-retina, then they transform into dormant bradyzoites which, enclosed in tissue cysts, occupy preferentially the brain, skeletal muscle and eye. Although T. gondii is able to infect all kinds of nucleated cells, it uses strictly defined host cells, dependent on the life-cycle phase and infection stage. The article discusses selected aspects of the parasite passing via the host body barriers as well as particular role of dendritic cells and skeletal muscle cells, used by the parasite as an very effective vehicle to disseminate throughout the host body or the site of long-term T. gondii persistence, respectively.

Słowa kluczowe

EN

Toxoplasma gondii; host cell; host barrier; dendritic cell; muscle cell; Protozoa; parasite; mammal; bird; prevalence

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2014
• Tom: 60
• Numer: 2
• Opis fizyczny: p.83-88,ref.

Twórcy

autor

Dlugonska H.

• Department of Immunoparasitology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland

Bibliografia

• [1] Furtado J.M., Smith J.R., Belfort R., Jr., Gattey D., Winthrop K.L. 2011. Toxoplasmosis: a global threat. Journal of Global Infectious Disease 3: 281-284.
• [2] Flegr J., Prandota J., Sovičkova ́M., Israili Z.H. 2014. Toxoplasmosis – a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries. PLoS One 9: e90203.
• [3] Morrissette N.S., Aijoka J.W. 2009. The early years of Toxoplasma research: What‘s past is prologue. International Journal for Parasitology 39: 865-869.
• [4] Gatkowska J., Wieczorek M., Dziadek B., Dzitko K., Długońska H. 2012. Behavioral changes in mice caused by Toxoplasma gondii invasion of brain Parasitology Research 111: 53-58.
• [5] McConkey, Martin H.L., Bristow G.C., Webster J.P. 2013. Toxoplasma gondii infection and behavior – location, location, location? The Journal of Experimental Biology 216: 113-119.
• [6] Tenter A.M. 2009. Toxoplasma gondii in animals used for human consumption. Memórias do Instituto Oswaldo Cruz 104: 364-369.
• [7] Jones J.L., Dubey J.P. 2012. Foodborne toxoplasmosis. Clinical Infectious Diseases 55: 845-851.
• [8] Håkansson S., Morisaki H., Heuser J., Sibley L.D. 1999. Time-lapse videomicroscopy of gliding motility in Toxoplasma gondii reveals a novel, biphasic mechanism of cell locomotion. Molecular Biology of the Cell 10: 3539-3547.
• [9] Barragan A., Sibley L.D. 2003. Migration of Toxoplasma gondii across biological barriers. Trends in Microbiology 11: 426-430.
• [10] Lambert H., Barragan A. 2010. Modelling parasite dissemination: host cell subversion and immune evasion by Toxoplasma gondii. Cellular Microbiology 12: 292–300.
• [11] Medawar P.B. 1948. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. British Journal of Experimental Pathology 1948, 29: 58-69.
• [12] Cobold S.P. 2009. Future therapeutics for the induction peripheral immune tolerance in autoimmune disease and organ transplantation. Immunotherapy 1: 447-460.
• [13] Cuffy M.C., Silverio A.M., Qin L., Wang Y., Eid R., Brandacher G., Lakkis F.G., Fuchs D., Pober J.S., Tellides G. 2001. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-γ contributes to medial immunoprivilige. The Journal of Immunology 179: 5246-5254.
• [14] Robert-Gangneux F. Dardé M.L. 2012. Epidemiology of and diagnostic strategies for toxoplasmosis epidemiology. Clinical and Microbiology Reviews 25: 264-296.
• [15] Feustel S.M., Meissner M, Liesenfeld M. 2012. Toxoplasma gondii and the blood-brain barrier. Virulence 3: 182-192.
• [16] Harker K., Jivan E., McWhorter F.Y., Liu W.F., Lodoen M.B. 2014. Shear forces enhance Toxoplasma gondii tachyzoite motibility in vascular endothelium. mBio 5: e01111-13.
• [17] Barragan A., Sibley L.D. 2002. Transepithelial migration of Toxoplasma gondii is linked to parasite motility and virulence. Journal of Experimental Medicine 195: 1625-1633.
• [18] Berenreiterová M., Flegr J., Kuběna A.A., Neměc P. 2011. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS One 6: e28925.
• [19] Melzer T.C, Cranston H.J, Weiss L.M., Halonen S.K. 2010. Host cell preference of Toxoplasma gondii cysts in murine brain: a confocal study. Journal of Neuroparasitology, 1: pii: N100505.
• [20] Dellasca-Lindberg I., Hitziger N, Barragan A. 2007. Localized recrudescence of Toxoplasma infections in central nervous system of immunocompromised mice assessed by in vivo bioluminescence imaging. Microbes and Infection 9: 1291-1298.
• [21] Forrester J.V., Dick A.D., McMenamin P.G., Roberts F. 2008. The eye: basic science in practice. Saunders Elsevier, Edinburgh.
• [22] Forrester J.V., Xu H. 2012. Good news-bad news: the Yin and Yang of immune privilege in the eye. Frontiers in Immunology 3: 1-18.
• [23] Furtado J.M., Bharadwaj A.S., Chipps T.J., Pan Y., Ashander L.M., Smith J.R. 2012. Toxoplasma gondii tachyzoites cross retinal endothelium assisted by intercellular adhesion molecule-1 in vitro. Immunology & Cell Biology 90; 912-915.
• [24] Furtado J.M., Ashander L.M., Mohs K., Chipps T.J., Appukuttan B., Smith J.R. 2013. Toxoplasma gondii migration within and infection of human retina. PLoS One 8: e54358.
• [25] Furtado J.M., Bharadwaj A.S., Ashander L.M., Olivas A., Smith J.R. 2012. Migration of Toxoplasma gondii-infected dendritic cells across human retinal vascular endothelium. Investigative Ophthalmology & Visual Science 53: 6856-6862.
• [26] Zeldovich V.B., Clausen C.H., Bradford E., Fletcher D.A., Maltepe E., Robbins J.R., Bakardjiev A.I. 2013. Placental syncytium forms a biophysical barrier against pathogen invasion. PLoS Pathogens 9: e1003821.
• [27] Robbins J.R., Zeldovich V.B., Poukchanski A., Boothroyd J.C., Bakardjiev A.I. 2012. Tissue barriers of the human placenta to infection with Toxoplasma gondii. Infection and Immunity 80: 418-428.
• [28] Collantes-Fernandez E., Arrighi R.B.G, Álvarez-Garcia G., Weidner J.M., Regidor-Cerrillo J., Boothroyd J.C., Ortega-Mora L.M., Barragan A. 2012. Infected dendritic cells facilitate systemic dissemination and transplacental passage of the obligate intracellular parasite Neospora caninum in mice. PLoS One 7: e32123.
• [29] Denkers E.I., Butcher B.A, Del Rio L., Bennouna S. 2004. Neutrophils, dendritic cells and Toxoplasma. International Journal for Parasitology 34: 411-421.
• [30] Dupont C.D., Christian D.A., Selleck E.M., Pepper M., Leney-Greene M., Harms Pritchard G., Koshy A.A., Wagage S., Reuter M.A., Siblez L.D., Betts M.R., Hunter C.A. 2014. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathogens 10: e1004047.
• [31] Weidner J.M., Kanatani S., Hernández-Castañeda M.A., Fuks J.M., Rethi B., Wallin R.P., Barragan A. 2013. Rapid cytoskeleton remodelling in dendritic cells following invasion by Toxoplasma gondii coincides with the onset of a hypermigratory phenotype. Cellular Microbiology 15: 1635-1652.
• [32] Weidner J.M., Barragan A. 2014. Tightly regulated migratory subversion of immune cells promotes the dissemination of Toxoplasma gondii. International Journal for Parasitology 44: 85-90.
• [33] Fuks J.M., Arrighi R.B., Weidner J.M., Kumar Mendu S., Jin Z., Wallin R.P., Rethi B., Birnir B., Barragan A. 2012. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Patogens 8: e1003051.
• [34] Dubey J.P. 1997. Tissue cyst tropism in Toxoplasma gondii; a comparison of tissue cysts formation in organs of cats, and rodents fed oocysts. Parasitology 115 (Pt 1): 15-20.
• [35] Swierzy I.J., Muhammad M., Kroll J., Abelmann A., Tenter A.M., Lűder C.G.K. 2013. Toxoplasma gondii within skeletal muscle cells: a critical interplay for food-born parasite transmission. International Journal for Parasitology 44: 91-98.
• [36] Cook A.J, Gilbert R.E., Buffolano W., Zufferey J., Petersen E., Jenum P.A., Foulon W., Semprini A.E., Dunn D.T. 2000. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 321: 142-147.
• [37] Zhang M., Joyce B.R., Sullivan W.J., Jr., Nussen -zweig V. 2013. Translational control in Plasmodium and Toxoplasma parasites. Eukaryotic Cell 12: 161-167
• [38] Huang J., Thayer M.J. 2002. Interactions between the cell cycle and the myogenic program. In: Advances in Developmental Biology and Biochemistry. (Ed. D. Sassoon). Elsevier: 53-74.
• [39] Radke J.R., Donald R.., Eibs A., Jerome M.E., Behnke M.S., Liberator P., White M.W. 2006. Changes in the expression of human cell division autoantigen-1 influence Toxoplasma gondii growth and development. PLoS Pathogens 2: e105.
• [40] Takács A.C., Swierzy I.J., Lűder C.G.K. 2012. Interferon-γ restricts Toxoplasma gondii development in murine skeletal muscle cells via nitric oxide production and immune immunity-related GTPases. PLoS One 7: e45440.
• [41] Dubremetz J.F., Lebrun M. 2012. Virulence factors of Toxoplasma gondii. Microbes and Infection 14: 1403-1410.
• [42] de Moura L., Bahia-Oliveira L.M., Wada M.Y., Jones J.L., Tuboi S.H., Carmo E.H., Ramalho W.M., Camargo N.J., Trevisan R., Graça R.M.T, da Silva A.J., Moura I., Dubey J.P., Garrett D.O. 2006. Waterborne toxoplasmosis, Brazil, from field to gene. Emerging Infectious Diseases 12: 326329.
• [43] Demar M., Hommel D., Djossou F., Peneau C., Boukhari R., Louvel D., Bourbigot A.M., Nasser V., Ajzenberg D., Darde M.L., Carme B. 2012. Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana. Clinical Microbiology and Infection 18: E221-231.
• [44] Sanecka A., Frickel E.M. 2012. Use and abuse of dendritic cells by Toxoplasma gondii. Virulence 3: 678-689.